Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
T(H)17 lymphocytes appear to be essential in the pathogenesis of numerous inflammatory diseases. We demonstrate here the expression of IL-17 and IL-22 receptors on blood-brain barrier endothelial cells (BBB-ECs) in multiple sclerosis lesions, and show that IL-17 and IL-22 disrupt BBB tight junctions in vitro and in vivo. Furthermore, T(H)17 lymphocytes transmigrate efficiently across BBB-ECs, highly express granzyme B, kill human neurons and promote central nervous system inflammation through CD4+ lymphocyte recruitment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In turn, IL-17 further impairs BBB integrity, thus allowing more immune cells and cytokines to gain easy access to the CNS [65, 66].”
From Chronic stress-induced depression requires the recruitment of peripheral Th17 cells into the brain (2022) · cites this paper as [66]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“IL-17 impairs blood–brain barrier integrity, allowing for more immune cells to cross into the CNS [127,128].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [128]
The cited source says what the claim attributes to it.
In the citing paper
“a subset of CD4+ T cells that is a major contributor to the pathogenicity of several inflammatory and autoimmune conditions (9–11)”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“inflammatory subtypes of T cells, particularly Th17 cells, are clearly deleterious in diseases such as multiple sclerosis (9–11, 24)”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“Th17 cells are deleterious to the CNS”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., & Iwakura, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.566 · Cited by 1,536
Steinman, L. (2007) · Nature Medicine · doi:10.1038/nm1551 · Cited by 1,376
Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis
Bettelli, E., Sullivan, B., Szabo, S. J., Sobel, R. A., Glimcher, L. H., & Kuchroo, V. K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031819 · Cited by 488
Wosik, K., Cayrol, R., Dodelet-Devillers, A., Berthelet, F., Bernard, M., Moumdjian, R., Bouthillier, A., Reudelhuber, T. L., & Prat, A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2088-07.2007 · Cited by 259
Self-citationExpression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes
Chung, Y., Yang, X., Chang, S. H., Ma, L., Tian, Q., & Dong, C. (2006) · Cell Research · doi:10.1038/sj.cr.7310106 · Cited by 231
Cited by
Items 201–300 of 1,003
Balasa, R., Barcutean, L., Mosora, O., & Manu, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168370 · Cited by 158
“As an example, the Th 17 cells, with the high expression of granzyme B, attain increased migratory capacity on arrival in the CNS and continue to stimulate demyelination and extensive axonal degeneration through the following: (1) direct interaction with myelin oligodendrocyte glycoprotein; (2) Th 17 cells secretion o…”
BackgroundIshrat, T., Sayeed, I., Atif, F., Hua, F., & Stein, D. G. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.08.023 · Cited by 159
Hucke, S., Eschborn, M., Liebmann, M., Herold, M., Freise, N., Engbers, A., Ehling, P., Meuth, S. G., Roth, J., Kuhlmann, T., et al. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.11.001 · Cited by 158
Crosstalk between Inflammation and the BBB in Stroke
Huang, Y., Chen, S., Luo, Y., & Han, Z. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200620230321 · Cited by 166
“Migration of Th17 cells across the BBB into the brain can increase IL-17 secretion and thus generate a pro-inflammatory response in the brain to increase lymphocyte recruitment and cytokine secretion [72, 73].”
BackgroundPasquin, S., Sharma, M., & Gauchat, J. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.007 · Cited by 164
Melatonin: A review of its potential functions and effects on neurological diseases
Günata, M., Parlakpınar, H., & Acet, A. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2019.07.025 · Cited by 170
Interleukin-17A: The Key Cytokine in Neurodegenerative Diseases
Chen, J., Liu, X., & Zhong, Y. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.566922 · Cited by 164
The Immunology of Multiple Sclerosis
Bar‐Or, A. (2008) · Seminars in Neurology · doi:10.1055/s-2007-1019124 · Cited by 184
Hu, Y., Ota, N., Peng, I., Refino, C. J., Danilenko, D. M., Caplazi, P., & Ouyang, W. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903614 · Cited by 174
Environmental factors in autoimmune diseases and their role in multiple sclerosis
Haase, S., Grohme, D. A., Erzler, M., Binsfeld, M., Haghikia, A., Müller, D. N., Linker, R. A., & Kleinewietfeld, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2311-1 · Cited by 167
“Moreover, it was found that Th17 cells are able to cross the inflamed blood–brain barrier and secrete the proinflammatory cytokine IL-17A [50].”
BackgroundStructure and Junctional Complexes of Endothelial, Epithelial and Glial Brain Barriers
Castro Dias, M., Mapunda, J. A., Vladymyrov, M., & Engelhardt, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215372 · Cited by 156
Darlington, P. J., Touil, T., Doucet, J.-S., Gaucher, D., Zeidan, J., Gauchat, D., Corsini, R., Kim, H. J., Duddy, M., Jalili, F., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23784 · Cited by 152
“In this context, IL-17 has been shown to directly contribute to disruption of tight junctions of human blood–brain barrier (BBB) endothelial cells, and Th17 cells were found to very efficiently migrate across the BBB, where they promoted further CD4þ lymphocyte recruitment.(22) Because the reduction in the ability to…”
BackgroundSelf-citationAlvarez, J. I., Saint-Laurent, O., Godschalk, A., Terouz, S., Briels, C., Larouche, S., Bourbonnière, L., Larochelle, C., & Prat, A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.09.016 · Cited by 150
Self-citationFingolimod may support neuroprotection via blockade of astrocyte nitric oxide
Colombo, E., Di Dario, M., Capitolo, E., Chaabane, L., Newcombe, J., Martino, G., & Farina, C. (2014) · Annals of Neurology · doi:10.1002/ana.24217 · Cited by 152
Disturbed regulatory T cell homeostasis in multiple sclerosis
Venken, K., Hellings, N., Liblau, R., & Stinissen, P. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.12.003 · Cited by 171
dos Passos, G. R., Sato, D. K., Becker, J., & Fujihara, K. (2016) · Mediators of Inflammation · doi:10.1155/2016/5314541 · Cited by 171
“In vitro and in vivo studies have shown that, through the action of IL-17A and IL-22, Th17 cells can efficiently disrupt BBB tight junctions, express high levels of the cytolytic enzyme granzyme B, and promote the recruitment of additional CD4+ lymphocytes from the systemic circulation into the CNS [36].”
BackgroundHäusser‐Kinzel, S., & Weber, M. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00201 · Cited by 182
Nadeem, A., Ahmad, S. F., Al-Harbi, N. O., Fardan, A. S., El-Sherbeeny, A. M., Ibrahim, K. E., & Attia, S. M. (2017) · Cytokine · doi:10.1016/j.cyto.2017.05.018 · Cited by 147
Kalim, K. W., Basler, M., Kirk, C. J., & Groettrup, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201183 · Cited by 179
Activated CD8+ T Cells Cause Long-Term Neurological Impairment after Traumatic Brain Injury in Mice
Daglas, M., Draxler, D. F., Ho, H., McCutcheon, F. M., Galle, A., Au, A. E., Larsson, P., Gregory, J. L., Alderuccio, F., Sashindranath, M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.046 · Cited by 182
SIRT1 deacetylates RORγt and enhances Th17 cell generation
Lim, H. W., Kang, S. G., Ryu, J. K., Schilling, B., Fei, M., Lee, I. S., Kehasse, A., Shirakawa, K., Yokoyama, M., Schnölzer, M., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20132378 · Cited by 148
“Maintaining the appropriate balance between T reg and T eff cell function is critical to the maintenance of immune self-tolerance, and aberrant function of T helper 17 (Th17) effector cells has been implicated in the onset and pathogenesis of multiple autoimmune diseases, including multiple sclerosis (Kebir et al., 20…”
Emerging Insights into Barriers to Effective Brain Tumor Therapeutics
Woodworth, G. F., Dunn, G. P., Nance, E. A., Hanes, J., & Brem, H. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00126 · Cited by 146
“Blood brain barrier disruption may also be achieved using osmotic agents (114) (e.g.,mannitol),pro-inflammatory cytokines (e.g., IL-17) (115, 116), or blood vessel modulators (e.g., RMP-7) (117).”
BackgroundGenome-wide association scan yields new insights into the immunopathogenesis of psoriasis
Elder, J. (2009) · Genes and Immunity · doi:10.1038/gene.2009.11 · Cited by 158
Larochelle, C., Cayrol, R., Kebir, H., Alvarez, J. I., Lécuyer, M.-A., Ifergan, I., Viel, É., Bourbonnière, L., Beauseigle, D., Terouz, S., et al. (2012) · Brain · doi:10.1093/brain/aws212 · Cited by 145
“A modified Boyden chamber assay was used to model the blood–brain barrier, as previously reported (Ifergan et al., 2006; Kebir et al., 2007; Cayrol et al., 2008).”
BackgroundMethodInfluentialSelf-citationNerurkar, P. V., Johns, L. M., Buesa, L. M., Kipyakwai, G., Volper, E., Sato, R., Shah, P., Feher, D., Williams, P. G., & Nerurkar, V. R. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-64 · Cited by 143
“HFD-induced neuroinflammation is characterized by BBB disruption, transmigration of activated lymphocytes as well as activation of microglial cells by infiltrating immune cells leading to increased production of proinflammatory cytokines such as IL-16 [30,31].”
BackgroundInfluentialNeuroimmune mechanisms and therapies mediating post-ischaemic brain injury and repair
Shichita, T., Ooboshi, H., & Yoshimura, A. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00690-0 · Cited by 169
TH17 cytokines in autoimmune neuro-inflammation
Becher, B., & Segal, B. M. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.08.005 · Cited by 142
Self-citationFingolimod for the treatment of neurological diseases—state of play and future perspectives
Brunkhorst, R., Vutukuri, R., & Pfeilschifter, W. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00283 · Cited by 167
“TH17 cells produce proinflammatory IL-17 and IL-22, transmigrate efficiently across the BBB, disrupt tight junctions, highly express neurotoxic substances, and promote CNS inflammation through additional CD4+ T cell and neutrophil recruitment (Kebir et al., 2007).”
BackgroundBlood-Brain Barrier Disruption Induced by Chronic Sleep Loss: Low-Grade Inflammation May Be the Link
Hurtado‐Alvarado, G., Domínguez-Salazar, E., Pavón, L., Velázquez‐Moctezuma, J., & Gómez‐González, B. (2016) · Journal of Immunology Research · doi:10.1155/2016/4576012 · Cited by 154
The IL‐17 pathway as a major therapeutic target in autoimmune diseases
Hu, Y., Shen, F., Crellin, N. K., & Ouyang, W. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05825.x · Cited by 156
Clinical associations of serum interleukin-17 in systemic lupus erythematosus
Vincent, F. B., Northcott, M., Hoi, A. Y.-B., Mackay, F., & Morand, E. F. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4277 · Cited by 149
“An in vitro study has shown that human Th17 cells may be well equipped to breach the blood-brain barrier and infiltrate the CNS parenchyma [37].”
Schneider‐Hohendorf, T., Rossaint, J., Mohan, H., Böning, D., Breuer, J., Kuhlmann, T., Groß, C. C., Flanagan, K., Sorokin, L. M., Vestweber, D., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20140540 · Cited by 155
“1843 pathology (Kebir et al., 2007) but also in CNS immune surveillance (Axtell and Steinman, 2009).”
Minireview: glucocorticoids in autoimmunity: unexpected targets and mechanisms
Flammer, J. R., & Rogatsky, I. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-0068 · Cited by 140
Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus
Martin, J. C., Baeten, D., & Josien, R. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.05.004 · Cited by 148
The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases
Zang, X., Chen, S., Zhu, J., Ma, J., & Zhai, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.872134 · Cited by 139
“In addition, the authors showed that the migration of neutrophils produces IL-17 in the cortex and hippocampus, which not only has a direct toxic effect on neurons and is involved in the disruption of the BBB but recruits additional neutrophils (Kebir et al., 2007; Zenaro et al., 2015).”
BackgroundThe Gut Microbiome and Multiple Sclerosis
Ochoa‐Repáraz, J., Kirby, T. O., & Kasper, L. H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029017 · Cited by 146
“1999), as well as an enhanced expression of IL-17 receptor (IL-17R) and IL-22 receptor (IL22R) in the vessels of MS lesions when compared to the vessels of healthy individuals (Kebir et al. 2007).”
BackgroundSun, Y., Tian, T., Gao, J., Liu, X., Hou, H., Cao, R., Li, B., Quan, M., & Guo, L. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.01.014 · Cited by 154
“IL-17A and IL-22 act on endothelial cells directly and sequentially disrupt the blood–brain barrier (BBB) tight junctions (Kebir et al., 2007).”
BackgroundPathophysiology of multiple sclerosis
Korn, T. (2008) · Journal of Neurology · doi:10.1007/s00415-008-6001-2 · Cited by 184
Novel therapeutic strategies targeting innate immune responses and early inflammation after stroke
Shichita, T., Ago, T., Kamouchi, M., Kitazono, T., Yoshimura, A., & Ooboshi, H. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07941.x · Cited by 136
“IL-17 also modulates the epithelial barrier function by promoting the expression of MMPs and ICAM-1 (Kebir et al. 2007; Ifergan et al. 2008).”
InfluentialZhou, Y., Sonobe, Y., Akahori, T., Jin, S., Kawanokuchi, J., Noda, M., Iwakura, Y., Mizuno, T., & Suzumura, A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003307 · Cited by 138
Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders
Machhi, J., Kevadiya, B. D., Muhammad, I. K., Herskovitz, J., Olson, K. E., Mosley, R. L., & Gendelman, H. E. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00375-7 · Cited by 147
“Teffs (Th1 and Th17) influence and maintain microglia proinflammatory phenotypes via secretion of IFN-γ and IL17 or release of granzyme B [101, 102].”
Multiple sclerosis: molecular pathogenesis and therapeutic intervention
Boutitah-Benyaich, I., Eixarch, H., Villacieros‐Álvarez, J., Hervera, A., Cobo‐Calvo, Á., Montalbán, X., & Espejo, C. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02415-4 · Cited by 160
“…characterized by the production of IL-17A, IL-17F, granulocyte ‒ macrophage colony-stimulating factor (GM ‒ CSF), IL-6, IL-21, IL-22, TNF-γ and the cytolytic enzyme granzyme B. 247,248 Importantly, Th17 cells were identi fi ed as essential players in the establishment of CNS in fl ammation in EAE.”
Luchtman, D. W., Ellwardt, E., Larochelle, C., & Zipp, F. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.013 · Cited by 144
“expression and of endothelial cell (EC) contractility [83,94,95].”
BackgroundCrabé, S., Guay-Giroux, A., Tormo, A. J., Duluc, D., Lissilaa, R., Guilhot, F., Mavoungou-Bigouagou, U., Lefouili, F., Cognet, I., Ferlin, W., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901464 · Cited by 134
“These results show that p28 and p28/CLF can have regulatory effects which differ from IL-27 regarding the production of IL-17, a cytokine which plays a pivotal role in several autoimmune diseases (59, 60).”
BackgroundSchulze-Topphoff, U., Prat, A., Prozorovski, T., Siffrin, V., Paterka, M., Herz, J., Bendix, I., Ifergan, I., Schadock, I., Mori, M. A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1980 · Cited by 131
Self-citationRegulation of IL-17 in Human CCR6+ Effector Memory T Cells
Liu, H., & Rohowsky-Kochan, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.7948 · Cited by 131
“Recently, one study reported that numerous CD45RO cells immunopositive for IL-17 or IL-22 were found in multiple sclerosis lesions (25).”
BackgroundImmune cell trafficking from the brain maintains CNS immune tolerance.
Mohammad, M., Tsai, V., Ruitenberg, M., Hassanpour, M., Li, H., Hart, P., Breit, S., Sawchenko, P., & Brown, D. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71544 · Cited by 116
“Disease-pro-moting Th cells also directly penetrate the intact blood-brain barrier (4), and circulating APCs may also access the CNS parenchyma under normal conditions (5), mediating pathogenic T cell entry (6).”
T Helper Lymphocyte Subsets and Plasticity in Autoimmunity and Cancer: An Overview
Ivanova, E. A., & Orekhov, A. N. (2015) · BioMed Research International · doi:10.1155/2015/327470 · Cited by 166
“cells in the disease pathogenesis has not been elucidated so far, it has been proposed that these cells might be involved in the disruption of the blood-brain barrier [118].”
BackgroundEomesodermin-expressing T-helper cells are essential for chronic neuroinflammation
Raveney, B. J. E., Oki, S., Hohjoh, H., Nakamura, M., Sato, W., Murata, M., & Yamamura, T. (2015) · Nature Communications · doi:10.1038/ncomms9437 · Cited by 136
Th17 and Cognitive Impairment: Possible Mechanisms of Action
Cipollini, V., Anrather, J., Orzi, F., & Iadecola, C. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00095 · Cited by 146
“Further support to the link between Th17 cells, IL-17 and MS relapses comes from the observation that human Th17 cells are able to cross the bloodbrain barrier (BBB) in MS lesions, enhancing neuroinflammation (Kebir et al., 2007).”
BackgroundInfluentialTh17 Pathway-Mediated Immunopathogenesis of Schizophrenia: Mechanisms and Implications
Debnath, M., & Berk, M. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu049 · Cited by 129
Ifergan, I., Kebir, H., Alvarez, J. I., Marceau, G., Bernard, M., Bourbonniere, L., Poirier, J., Duquette, P., Talbot, P. J., Arbour, N., et al. (2011) · Brain · doi:10.1093/brain/awr268 · Cited by 130
“that IL-17 secreted by T lymphocytes can disrupt endothelial and epithelial barriers (Kebir et al., 2007).”
BackgroundMethodSelf-citationShekhar, S., Cunningham, M., Pabbidi, M. R., Wang, S., Booz, G. W., & Fan, F. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.06.028 · Cited by 136
Intrinsic blood–brain barrier dysfunction contributes to multiple sclerosis pathogenesis
Nishihara, H., Perriot, S., Gastfriend, B. D., Steinfort, M., Cibien, C., Soldati, S. G., Matsuo, K., Guimbal, S., Mathias, A., Palecek, S. P., et al. (2022) · Brain · doi:10.1093/brain/awac019 · Cited by 141
Role of dopamine in the physiology of T-cells and dendritic cells
Pacheco, R., Prado, C. E., Barrientos, M. J., & Bernales, S. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.07.018 · Cited by 142
“A study performed in a model of human BBB in vitro has determined that IL-17R and IL-22R are up-regulated on the surface of endothelial cells of BBB in MS lesions (Kebir et al., 2007).”
BackgroundDileepan, T., Smith, E. D., Knowland, D., Hsu, M., Platt, M., Bittner-Eddy, P., Cohen, B., Southern, P., Latimer, E., Harley, E., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80792 · Cited by 128
“IL-17A disrupts TJs between endothelial cells in human MS and the EAE rodent model (19, 21), and Th17 cells were shown to form persistent synapse-like associations with neurons, resulting in loss of function (50).”
BackgroundDaniels, B. P., Cruz‐Orengo, L., Pasieka, T. J., Couraud, P., Romero, I. A., Weksler, B. B., Cooper, J. A., Doering, T. L., & Klein, R. S. (2012) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2012.10.001 · Cited by 148
“Key studies have used an in vitro BBB model to study immune migration across the BBB during inflammatory episodes in the CNS (Kebir et al. 2007; Man et al. 2012).”
BackgroundWong, H., & Hoeffer, C. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.04.010 · Cited by 129
“…A uthor M anuscript brain pathology not only in MS and experimental autoimmune encephalomyelitis (EAE), a mouse model for MS, but also in epilepsy and ischemia (Das Sarma et al., 2009; He et al., 2013; Kawanokuchi et al., 2008; Kebir et al., 2007; Komiyama et al., 2006; Wang et al., 2009).”
BackgroundInfluentialCytokines and effector T cell subsets causing autoimmune CNS disease
Petermann, F., & Korn, T. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.064 · Cited by 128
“Moreover IL-17R engagement increases the generation of reactive oxygen species (ROS) in brain endothelial cells resulting in disorganization of tight junctions and subsequently in blood brain barrier impairment [78,79].”
BackgroundTh17 cells, γδ T cells and their interplay in EAE and multiple sclerosis
McGinley, A. M., Edwards, S. C., Raverdeau, M., & Mills, K. H. G. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.01.001 · Cited by 145
Álvarez‐Sánchez, N., Cruz‐Chamorro, I., González, A. L., Utrilla, J. C., Fernández-Santos, J. M., Martínez‐López, A., Lardone, P. J., Guerrero, J. M., & Carrillo‐Vico, A. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.06.021 · Cited by 129
Myasthenia Gravis: Paradox versus paradigm in autoimmunity
Berrih‐Aknin, S. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.05.001 · Cited by 141
Neuroinflammation in Alzheimer’s disease: insights from peripheral immune cells
Zhang, Q., Yang, G., Luo, Y., Jiang, L., Chi, H., & Tian, G. (2024) · Immunity & Ageing · doi:10.1186/s12979-024-00445-0 · Cited by 154
“Neutro-phils produce IL-17, which can recruit additional neutrophils and directly damage neurons and the BBB [95].”
BackgroundZhu, E., Wang, X., Zheng, B., Wang, Q., Hao, J., Chen, S., Zhao, Q., Zhao, L., Wu, Z., & Yin, Z. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303488 · Cited by 127
“cells (1–4), which characterized critical pathological roles in several autoimmune disorders, such as multiple sclerosis (MS) (5), rheumatoid arthritis (6), and systemic lupus erythematosus (7).”
BackgroundMehling, M., Johnson, T., Antel, J. P., Kappos, L., & Bar‐Or, A. (2011) · Neurology · doi:10.1212/wnl.0b013e31820db341 · Cited by 128
Current and emerging disease‐modulatory therapies and treatment targets for multiple sclerosis
Piehl, F. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13215 · Cited by 125
Berry, S. P. D.-G., Dossou, C., Kashif, A., Sharifinejad, N., Azizi, G., Hamedifar, H., Sabzvari, A., & Zian, Z. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108402 · Cited by 124
Blood brain barrier and inflammation in depression
Medina-Rodriguez, E. M., & Beurel, E. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105926 · Cited by 123
SIRT1 deacetylates RORγt and enhances Th17 cell generation
Lim, H. W., Kang, S. G., Ryu, J. K., Schilling, B., Fei, M., Lee, I. S., Kehasse, A., Shirakawa, K., Yokoyama, M., Schnölzer, M., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.2013237805062015c · Cited by 122
“Maintaining the appropriate balance between T reg and T eff cell function is critical to the maintenance of immune self-tolerance, and aberrant function of T helper 17 (Th17) effector cells has been implicated in the onset and pathogenesis of multiple autoimmune diseases, including multiple sclerosis (Kebir et al., 20…”
Pathogenic T cell cytokines in multiple sclerosis
Wagner, C. A., Roqué, P. J., & Goverman, J. M. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190460 · Cited by 145
Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype
Kozela, E., Juknat, A., Kaushansky, N., Rimmerman, N., Ben‐Nun, A., & Vogel, Z. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9493-1 · Cited by 129
“IL-17 cytokine, produced by a specific class of helper/effector autoreactive T cells defined as Th17 (Harrington et al. 2005), has been suggested to serve as a critical factor in autoimmune diseases (Kebir et al. 2007; Fouser et al. 2008).”
BackgroundGanea, D., HOOPER, K. M., & Kong, W. (2014) · Acta Physiologica · doi:10.1111/apha.12427 · Cited by 128
“Th17 cells play a major role in autoimmunity, dominating the inflammatory response in RA, MS, psoriasis and Crohn’s disease (Fujino et al. 2003, Kebir et al. 2007, Bovenschen et al. 2011, Ferraccioli & Zizzo 2011).”
BackgroundTH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic?
Marwaha, A., Leung, N. J., McMurchy, A. N., & Levings, M. K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00129 · Cited by 146
The Properties of Cytokines in Multiple Sclerosis: Pros and Cons
Wang, K., Song, F., Fernandez-Escobar, A., Luo, G., Wang, J., & Sun, Y. S. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.08.018 · Cited by 129
“IL-22 regulates immunity at the barrier surface and contributes to MS severity.(39) In CNS, astrocytes express the subunits of the IL-22 receptor, and immunohistochemistry study confirms that there is a colocalization of IL-22 with astrocytes, suggesting that astrocytes might be a key player in the IL-22-mediated path…”
BackgroundMa, J., McCarl, C., Khalil, S. D. S., Lüthy, K., & Feske, S. (2010) · European Journal of Immunology · doi:10.1002/eji.201040614 · Cited by 130
Mao, L., Ding, J., Peng, W., Ma, Y., Zhang, Y., Fan, W., & Wang, X. (2013) · Epilepsia · doi:10.1111/epi.12337 · Cited by 129
“We speculate that IL-17A disrupts the integrity of the tight junctions, which promote the transmigration of Th17 or other active T cells across the blood– brain barrier (Kebir et al., 2007), which in turn aggravates seizure attack.”
BackgroundZhao, L., Li, Z., Vong, J. S. L., Chen, X., Lai, H. M., Yan, L. Y. C., Huang, J., Sy, S. K. H., Tian, X. Y., Huang, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18249-3 · Cited by 141
Bhaumik, S., & Basu, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00254 · Cited by 119
“In both IBD and experimental autoimmune encephalomyelitis (EAE), Th17 cells grown in presence of TGFβ are also shown to be pathogenic, which clearly limits the correlation of TGFβ with non-pathogenic function of Th17 cells (29, 59, 83).”
BackgroundOh, K., Park, H.-B., Byoun, O.-J., Shin, D.-M., Jeong, E. M., Kim, Y. W., Kim, Y. S., Melino, G., Kim, I.-G., & Lee, D.-S. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101457 · Cited by 118
“Th17 cells have been implicated in various autoimmune diseases, including multiple sclerosis (Kebir et al., 2007) and psoriasis (Di Cesare et al.”
BackgroundRegulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation
Yu, J., Zhou, X., Chang, M., Nakaya, M., Chang, J.-H., Xiao, Y., William Lindsey, J., Dorta-Estremera, S., Cao, W., Zal, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms7074 · Cited by 118
“In vitro T-cell migration assays were performed using a 24-well plate Boyden chamber essentially as previously described 33 .”
Neurodegeneration in autoimmune CNS inflammation
Herz, J., Zipp, F., & Siffrin, V. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.11.019 · Cited by 134
“In vitro generated human CD4+ Th17 cells expressed granzyme B and showed cytolytic activity in human fetal neuron-enriched cultures (Kebir et al., 2007).”
Golzari, Z., Shabkhiz, F., Soudi, S., Kordi, M. R., & Hashemi, S. M. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.08.008 · Cited by 145
“have showed that the endothelial cells express high levels of IL-17 receptors and are more permeable in response to IL-17, and promote CNS inflammation in MS patients [33].”
BackgroundSkihar, V., Silva, C., Chojnacki, A., Döring, A., Stallcup, W. B., Weiss, S., & Yong, V. W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909607106 · Cited by 120
“Importantly, Th2 cells have not been found to be neurotoxic, unlike the proinflammatory Th1 or Th17 lymphocytes that destroy neurons in tissue culture (12).”
Dual roles of PGE 2 -EP4 signaling in mouse experimental autoimmune encephalomyelitis
Esaki, Y., Li, Y., Sakata, D., Yao, C., Segi-Nishida, E., Matsuoka, T., Fukuda, K., & Narumiya, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915112107 · Cited by 113
“A recent study showed that human Th17 cells preferentially migrate across a layer of humanBBB endothelial cells in vitro, that humanBBB endothelial cells in MS lesions express both IL-17 receptors and IL-22 receptors in vivo, and that IL-17 down-regulates expression of tight junction molecules, such as occludin and zo…”
BackgroundRiedhammer, C., & Weissert, R. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00322 · Cited by 147
“IL-17 transcripts have been shown increased especially in chronic silent MS lesions (82) and IL-17 positive cells were also found increased in MS lesions (96).”
BackgroundCurcumin has bright prospects for the treatment of multiple sclerosis
Xie, L., Li, X., & Takahara, S. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.08.013 · Cited by 118
Principles of inflammasome priming and inhibition: implications for psychiatric disorders
Herman, F. J., & Pasinetti, G. M. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.06.010 · Cited by 115
Ronchi, F., Basso, C., Preite, S., Reboldi, A., Baumjohann, D., Perlini, L., Lanzavecchia, A., & Sallusto, F. (2016) · Nature Communications · doi:10.1038/ncomms11541 · Cited by 115
Acquired immunodeficiency syndrome and the blood-brain barrier
Ivey, N. S., MacLean, A. G., & Lackner, A. A. (2009) · Journal of Neurovirology · doi:10.1080/13550280902769764 · Cited by 115
“Decreases in zo-1 have been correlated with increased permeability of the tight junction, and BBB disruption in general (Anathbandhu et al, 2007; Kebir et al, 2007).”
BackgroundDuffy, S. S., Lees, J. G., & Moalem‐Taylor, G. (2014) · Multiple Sclerosis International · doi:10.1155/2014/285245 · Cited by 140
“On the other hand, increased IL-17 expression has been correlated with active or relapsing MS [84, 85], and IL-17 receptors on BBB endothelial cells in MS lesions have been implicated as a possible mechanism by which immune cells infiltrate the CNS during MS via disruption of BBB tight junctions [86].”
BackgroundDepression and suicidality: A link to premature T helper cell aging and increased Th17 cells
Schiweck, C., Valles-Colomer, M., Arolt, V., Müller, N., Raes, J., Wijkhuijs, A., Claes, S., Drexhage, H., & Vrieze, E. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.02.005 · Cited by 114
Dimitrov, D. H., Lee, S., Yantis, J., Valdez, C., Paredes, R. M., Braida, N., Velligan, D. I., & Walss‐Bass, C. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.10.019 · Cited by 128
Lutz, S. E., Smith, J. R., Kim, D. H., Olson, C. V. L., Ellefsen, K., Bates, J. M., Gandhi, S. P., & Agalliu, D. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.094 · Cited by 120
“, 2010), a cytokine that disrupts tight junctions (Kebir et al., 2007).”
Dietert, R. R., & Dietert, J. M. (2008) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937400802370923 · Cited by 113
Glial-endothelial crosstalk regulates blood–brain barrier function
Cheslow, L., & Alvarez, J. I. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.09.010 · Cited by 125
Liu, Z., Huang, Y., Cao, B.-B., Qiu, Y.-H., & Peng, Y.-P. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0249-9 · Cited by 112
Therapeutic potential of curcumin for multiple sclerosis
Qureshi, M., Al-Suhaimi, E. A., Wahid, F., Shehzad, O., & Shehzad, A. (2017) · Neurological Sciences · doi:10.1007/s10072-017-3149-5 · Cited by 124
“Migration of Th17 cells across BBB-ECS stimulates inflammation of CNS through mobilization of lymphocytes [38].”
BackgroundInfluentialFlannigan, K. L., & Denning, T. L. (2018) · Immunology · doi:10.1111/imm.12950 · Cited by 121
Balasa, R., Barcutean, L., Balasa, A., Motataianu, A., Roman-Filip, C., & Manu, D. (2020) · Human Immunology · doi:10.1016/j.humimm.2020.02.009 · Cited by 107
Masuda, M., Matsumoto, M., Tanaka, S., Nakajima, K., Yamada, N., 井戸, 信., Ohtsuka, T., Nishida, M., Hirano, T., & Utsumi, H. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.03.016 · Cited by 118
“The presence of Th17 cells appears to be associated with autoimmune diseases such as multiple sclerosis (Kebir et al., 2007) and rheumatoid arthritis (Kotake et al.”
Background
Metadata
- Authors
- Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A.
- Affiliations
- University of Zurich (CH)
- Hôpital Notre-Dame (CA)
- University of Alberta (CA)
- Corresponding author
- Prat, Alexandre
- Venue
- Nature Medicine
- Published
- 2007-09-09
- Volume
- 13
- Issue
- 10
- Pages
- 1173-1175
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC5114125
- OpenAlex
- W1998000193
- Semantic Scholar
- d0c491686d390e0dfdffedd4e32222d5b6065fd7
- Cited by
- 1,759
- References
- 14
- Citations by year
- 2026: 69 · 2025: 78 · 2024: 85 · 2023: 116 · 2022: 104 · 2021: 86 · 2020: 96 · 2019: 87 · 2018: 98 · 2017: 98 · 2016: 90 · 2015: 94 · 2014: 97 · 2013: 106 · 2012: 86
- FWCI
- 54.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Funders
- Canadian Institutes of Health Research (79785_1)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- Th17 cells, blood-brain barrier, endothelial cells, IL-17, IL-22, tight junctions, multiple sclerosis, neuroinflammation, lymphocyte transmigration, granzyme B
- MeSH terms
- Blood-Brain Barrier, Cell Membrane Permeability, Cell Movement, Cells, Cultured, Central Nervous System, Dose-Response Relationship, Drug, Endothelium, Vascular, T-Lymphocytes, Helper-Inducer, Humans, Inflammation, Multiple Sclerosis, CD4-Positive T-Lymphocytes, Case-Control Studies, Receptors, Interleukin, Tight Junctions, Interleukin-17, Endothelial Cells, Granzymes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.